硫酸镁改善小鼠组蛋白诱导的凝血功能障碍和肺损伤
研究检测脓毒症患者和小鼠循环组蛋白水平,分析其与凝血参数及镁离子水平的关系;并通过静脉注射组蛋白建立小鼠凝血模型,评估硫酸镁的保护作用。结果发现脓毒症患者组蛋白水平与血小板计数负相关、与凝血酶原时间和D-二聚体正相关;盲肠结扎穿刺小鼠中组蛋白与血小板计数负相关、与D-二聚体正相关;组蛋白与镁离子水平正相关。动物实验证实硫酸镁给药显著改善小鼠生存率,减轻组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤。作者认为靶向组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤(例如使用硫酸镁)可能对循环组蛋白升高的脓毒症个体具有保护作用。
要点
- 脓毒症患者循环组蛋白水平与血小板计数负相关,与凝血酶原时间和D-二聚体水平正相关。
- 盲肠结扎穿刺小鼠中组蛋白与血小板计数负相关、与D-二聚体水平正相关。
- 脓毒症中组蛋白与镁离子水平呈正相关,提示具有抗凝活性的镁离子参与组蛋白介导的凝血改变。
- 小鼠静脉注射组蛋白模型中,硫酸镁给药显著改善生存率,减轻组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤。
- 作者认为靶向组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤(例如使用硫酸镁)可能对循环组蛋白升高的脓毒症个体具有保护作用。
适用人群与场景
- 脓毒症患者(采集血液标本测定循环组蛋白水平)
- 小鼠:盲肠结扎穿刺脓毒症模型及静脉注射组蛋白诱导的凝血模型
处置流程与药物剂量
- 小鼠静脉注射组蛋白建立凝血模型后给予硫酸镁,结果显示硫酸镁给药显著改善生存率并减轻组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤(原文未写明硫酸镁剂量、给药途径和频次)。
研究设计与关键结果
- 脓毒症患者中组蛋白水平与血小板计数负相关,与凝血酶原时间和D-二聚体水平正相关。
- 盲肠结扎穿刺小鼠中组蛋白与血小板计数负相关、与D-二聚体水平正相关。
- 脓毒症中组蛋白与镁离子水平呈正相关,提示具有抗凝活性的镁离子参与组蛋白介导的凝血改变。
- 小鼠静脉注射组蛋白后,硫酸镁给药显著改善生存率,减轻组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤;肺组织损伤评估采用苏木精-伊红染色、免疫组化、免疫荧光、电子显微镜和定量聚合酶链反应。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型)结合脓毒症患者血液标本的观察性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为靶向组蛋白介导的内皮细胞损伤、凝血功能障碍和肺损伤(例如使用硫酸镁)可能对循环组蛋白升高的脓毒症个体具有保护作用;该结论来自小鼠实验,原文未给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: Extracellular histones have been determined as significant mediators of sepsis, which can induce endothelial cell injury and promote coagulation activation, and ultimately contribute to multiorgan failure. Evidence suggests that magnesium sulfate (MgSO 4 ) exerts a potential coagulation-modulating activity; however, whether MgSO 4 ameliorates histone-induced coagulation dysfunction and organ damage remains unclear. Methods: To measure circulating histone levels, blood specimens were collected from septic patients and mice, and the relationship between circulating histone levels, coagulation parameters, and Mg 2+ levels in sepsis was investigated. Furthermore, to explore the possible protective effects of MgSO 4 , we established a histone-induced coagulation model in mice by intravenous histone injection. The survival rate of mice was assessed, and the histopathological damage of the lungs (including endothelial cell injury and coagulation status) was evaluated using various methods, including hematoxylin and eosin staining, immunohistochemistry, immunofluorescence, electron microscopy, and quantitative polymerase chain reaction. Results: The circulating histone levels in septic patients and mice were significantly associated with several coagulation parameters. In septic patients, histone levels correlated negatively with platelet counts and positively with prothrombin time and D-dimer levels. Similarly, in cecal ligation and puncture mice, histones correlated negatively with platelet counts and positively with D-dimer levels. Interestingly, we also observed a positive link between histones and Mg 2+ levels, suggesting that Mg 2+ with anticoagulant activity is involved in histone-mediated coagulation alterations in sepsis. Further animal experiments confirmed that MgSO 4 administration significantly improved survival and attenuated histone-mediated endothelial cell injury, coagulation dysfunction, and lung damage in mice. Conclusion: These results suggest that therapeutic targeting of histone-mediated endothelial cell injury, coagulation dysfunction, and lung damage, for example, with MgSO 4 , may be protective in septic individuals with elevated circulating histone levels.
参考来源
- Zhong T, Zhang J, Chen S, et al. MAGNESIUM SULFATE AMELIORATES HISTONE-INDUCED COAGULATION DYSFUNCTION AND LUNG DAMAGE IN MICE. Shock. 2023. PMID: 37988072. doi:10.1097/SHK.0000000000002263
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。